In the case of leukemia, Niu et al. [109] also showed that knockdown of BCR-ABL in chronic myeloid leukemia (CML) cells downregulated plakoglobin expression and suppressed β-catenin by activating GSK-3β [109]. This evidence concerns the gene GSK3B and chronic myelogenous leukemia, BCR-ABL1 positive.